Evaluation of the Tobbstop Mobile App for Smoking Cessation: Cluster Randomized Controlled Clinical Trial
BackgroundMobile apps provide an accessible way to test new health-related methodologies. Tobacco is still the primary preventable cause of death in industrialized countries, constituting an important public health issue. New technologies provide novel opportunities that are...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
JMIR Publications
2020-06-01
|
Series: | JMIR mHealth and uHealth |
Online Access: | http://mhealth.jmir.org/2020/6/e15951/ |
id |
doaj-1a9b6da566334ddb8156220dec4f9228 |
---|---|
record_format |
Article |
spelling |
doaj-1a9b6da566334ddb8156220dec4f92282021-05-03T04:33:05ZengJMIR PublicationsJMIR mHealth and uHealth2291-52222020-06-0186e1595110.2196/15951Evaluation of the Tobbstop Mobile App for Smoking Cessation: Cluster Randomized Controlled Clinical TrialPallejà-Millán, MeritxellRey-Reñones, CristinaBarrera Uriarte, Maria LuisaGranado-Font, EstherBasora, JosepFlores-Mateo, GemmaDuch, Jordi BackgroundMobile apps provide an accessible way to test new health-related methodologies. Tobacco is still the primary preventable cause of death in industrialized countries, constituting an important public health issue. New technologies provide novel opportunities that are effective in the cessation of smoking tobacco. ObjectiveThis paper aims to evaluate the efficacy and usage of a mobile app for assisting adult smokers to quit smoking. MethodsWe conducted a cluster randomized clinical trial. We included smokers older than 18 years who were motivated to stop smoking and used a mobile phone compatible with our mobile app. We carried out follow-up visits at 15, 30, and 45 days, and at 2, 3, 6, and 12 months. Participants of the intervention group had access to the Tobbstop mobile app designed by the research team. The primary outcomes were continuous smoking abstinence at 3 and 12 months. ResultsA total of 773 participants were included in the trial, of which 602 (77.9%) began the study on their D-Day. Of participants in the intervention group, 34.15% (97/284) did not use the app. The continuous abstention level was significantly larger in the intervention group participants who used the app than in those who did not use the app at both 3 months (72/187, 38.5% vs 13/97, 13.4%; P<.001) and 12 months (39/187, 20.9% vs 8/97, 8.25%; P=.01). Participants in the intervention group who used the app regularly and correctly had a higher probability of not being smokers at 12 months (OR 7.20, 95% CI 2.14-24.20; P=.001) than the participants of the CG. ConclusionsRegular use of an app for smoking cessation is effective in comparison with standard clinical practice. Trial RegistrationClinicaltrials.gov NCT01734421; https://clinicaltrials.gov/ct2/show/NCT01734421http://mhealth.jmir.org/2020/6/e15951/ |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Pallejà-Millán, Meritxell Rey-Reñones, Cristina Barrera Uriarte, Maria Luisa Granado-Font, Esther Basora, Josep Flores-Mateo, Gemma Duch, Jordi |
spellingShingle |
Pallejà-Millán, Meritxell Rey-Reñones, Cristina Barrera Uriarte, Maria Luisa Granado-Font, Esther Basora, Josep Flores-Mateo, Gemma Duch, Jordi Evaluation of the Tobbstop Mobile App for Smoking Cessation: Cluster Randomized Controlled Clinical Trial JMIR mHealth and uHealth |
author_facet |
Pallejà-Millán, Meritxell Rey-Reñones, Cristina Barrera Uriarte, Maria Luisa Granado-Font, Esther Basora, Josep Flores-Mateo, Gemma Duch, Jordi |
author_sort |
Pallejà-Millán, Meritxell |
title |
Evaluation of the Tobbstop Mobile App for Smoking Cessation: Cluster Randomized Controlled Clinical Trial |
title_short |
Evaluation of the Tobbstop Mobile App for Smoking Cessation: Cluster Randomized Controlled Clinical Trial |
title_full |
Evaluation of the Tobbstop Mobile App for Smoking Cessation: Cluster Randomized Controlled Clinical Trial |
title_fullStr |
Evaluation of the Tobbstop Mobile App for Smoking Cessation: Cluster Randomized Controlled Clinical Trial |
title_full_unstemmed |
Evaluation of the Tobbstop Mobile App for Smoking Cessation: Cluster Randomized Controlled Clinical Trial |
title_sort |
evaluation of the tobbstop mobile app for smoking cessation: cluster randomized controlled clinical trial |
publisher |
JMIR Publications |
series |
JMIR mHealth and uHealth |
issn |
2291-5222 |
publishDate |
2020-06-01 |
description |
BackgroundMobile apps provide an accessible way to test new health-related methodologies. Tobacco is still the primary preventable cause of death in industrialized countries, constituting an important public health issue. New technologies provide novel opportunities that are effective in the cessation of smoking tobacco.
ObjectiveThis paper aims to evaluate the efficacy and usage of a mobile app for assisting adult smokers to quit smoking.
MethodsWe conducted a cluster randomized clinical trial. We included smokers older than 18 years who were motivated to stop smoking and used a mobile phone compatible with our mobile app. We carried out follow-up visits at 15, 30, and 45 days, and at 2, 3, 6, and 12 months. Participants of the intervention group had access to the Tobbstop mobile app designed by the research team. The primary outcomes were continuous smoking abstinence at 3 and 12 months.
ResultsA total of 773 participants were included in the trial, of which 602 (77.9%) began the study on their D-Day. Of participants in the intervention group, 34.15% (97/284) did not use the app. The continuous abstention level was significantly larger in the intervention group participants who used the app than in those who did not use the app at both 3 months (72/187, 38.5% vs 13/97, 13.4%; P<.001) and 12 months (39/187, 20.9% vs 8/97, 8.25%; P=.01). Participants in the intervention group who used the app regularly and correctly had a higher probability of not being smokers at 12 months (OR 7.20, 95% CI 2.14-24.20; P=.001) than the participants of the CG.
ConclusionsRegular use of an app for smoking cessation is effective in comparison with standard clinical practice.
Trial RegistrationClinicaltrials.gov NCT01734421; https://clinicaltrials.gov/ct2/show/NCT01734421 |
url |
http://mhealth.jmir.org/2020/6/e15951/ |
work_keys_str_mv |
AT pallejamillanmeritxell evaluationofthetobbstopmobileappforsmokingcessationclusterrandomizedcontrolledclinicaltrial AT reyrenonescristina evaluationofthetobbstopmobileappforsmokingcessationclusterrandomizedcontrolledclinicaltrial AT barrerauriartemarialuisa evaluationofthetobbstopmobileappforsmokingcessationclusterrandomizedcontrolledclinicaltrial AT granadofontesther evaluationofthetobbstopmobileappforsmokingcessationclusterrandomizedcontrolledclinicaltrial AT basorajosep evaluationofthetobbstopmobileappforsmokingcessationclusterrandomizedcontrolledclinicaltrial AT floresmateogemma evaluationofthetobbstopmobileappforsmokingcessationclusterrandomizedcontrolledclinicaltrial AT duchjordi evaluationofthetobbstopmobileappforsmokingcessationclusterrandomizedcontrolledclinicaltrial |
_version_ |
1721484197133025280 |